 (Gut 1995; 36: 737-742) 
Short chain fatty acids are the predominant aqueous solutes of normal human stool, amounting to a total concentration of 100 to 240 mM. Short chain fatty acids mainly consist of acetic, propionic, and butyric acids, which are fermentation products from anaerobic bacteria in the large bowel. 1 Butyric acid, accounting for about 17% of the short chain fatty acids, cannot be produced by human cells but nevertheless seems to be the most important energy source for colonic epithelial cells in normal conditions.2A Decreased availability5-7 or impaired oxidation3 of short chain fatty acids and particularly butyrate might be associated with development of ulcerative colitis and diversion colitis. It has been speculated whether low butyrate consumption represents a metabolic failure that may, at least partly, explain the pathogenesis of ulcerative colitis.3 The possibility exists, however, that low consumption, if present, merely reflects enzymatic changes over time secondary to low butyrate concentrations with the gut lumen. It should be noted that two recent reports48 found no differences between patients with ulcerative colitis and controls when butyrate metabolism was measured in biopsy specimens. Thus, it seems that decreased supply of butyrate might be the factor participating in the pathogenesis of colitis.
Luminal butyrate deficiency probably evolves from shifts within the colonic bacterial flora, either spontaneously or after consumption of various antibiotics.9 It is noteworthy that enemas containing faeces from healthy donors,'0 11 possibly by reintroducing butyrate producing strains, or butyrate enemas6 7 can induce clinical improvement of ulcerative colitis, pseudomembranous enterocolitis, and diversion colitis. Moreover, taking into account the profound effects of butyrate in regulating the behaviour of cells in vitro,12 it might be speculated that differences in the luminal butyrate concentration itself can change several functions of the colonic mucosal barrier. Because immunological properties of intestinal epithelial cells have been extensively studied by our laboratory (for review, see reference 13) as well as their modulations by cytokines,14 '6 we wanted to study the effects of butyrate to this end in a well characterised experimental system.
Methods

Cell culture
The human colonic adenocarcinoma cell line HT-29m3 was used. These cells were subcloned from the HT-29m2 cell line previously selected for high expression of secretory component. ' antigen expression by fixed adherent cells was measured after primary labelling with mAbs followed by sequential incubations with rabbit antimouse IgG and peroxidase conjugated swine antirabbit IgG. The peroxidase dependent colour reaction was then measured as optical density (OD) at 492 nm. The actual cell counts for all wells were subsequently determined at OD550 n after crystal violet staining of the same microplate. 16 The following modifications were introduced to render the assays quantitative: reference cells (IFN and TNF stimulated HT-29m3 cells, 50 IU/ml of each cytokine for 24 hours) expressing high antigen values were grown at graded densities on each microplate. These standard cells were given an arbitrary value of 1000 units of each antigen per cell. A standard curve for each microplate was obtained from the reference wells by plotting CELISA OD492 nm values against the corresponding cell counts determined by crystal violet at OD550 nm. The Pearson correlation coefficients (r) in log-log standard plots were usually above 0-85. The antigen content in each test well was calculated from this standard curve by means of linear regression analysis; the amount of antigen per cell could finally be determined by correcting for the cell count expressed as OD550 nm in the actual test well.
Results of experiments from each test point were obtained as medians of quadruplicate measurements; differences between quadruplicates was tested by the two tailed MannWhitney U test. All CELISA microplates included both irrelevant control mAb and standard background OD without primary antibody. All experiments were repeated at least twice.
Slot blot and northern blot analysis Total RNA from HT-29m3 cells was prepared from cells that had been detached by rubber policeman, pelleted, and subsequently snap frozen in liquid nitrogen. The isolation of RNA by the guanidium isothiocyanate method and the preparation of slot blots and northern blots have been described in detail previously. '6 Densitometric analyses of suitably exposed slot blot autoradiograms were analysed for OD by a 2202 Ultroscan Laser Densitometer (LKB, Bromma, Sweden).
Results
Effects of butyrate on cell growth and morphology
Butyrate inhibited cell growth in a dose dependent manner, depending on the incubation time; after four days growth inhibition was about 25% for butyrate concentrations at Time (days) 4 5 Figure 2 (Fig 1) .
Kinetics of the butyrate effects and butyrate modulated cytokine responses HT-29m3 cells treated with 3 mM butyrate alone from one to five days showed a minimal increase of HLA class I and secretory component expression over time, whereas the HLA class II and ICAM-1 values remained negative (Fig 2) . After coincubation of IFN and TNF (both at 50 IU/ml) with butyrate for the last day, the cytokine mediated effects on antigen expression were differentially modulated over time: considerable enhancement of HLA class II and ICAM-1; slight enhancement of secretory component; and a comparative reduction of HLA class I (Fig 2) .
Effects of IL 1, IL 4, IFN, and TNF are differentially modulated by butyrate HT-29m3 cells were preincubated with 3 mM butyrate for 60 hours followed by 36 hours coincubation of butyrate and various cytokines alone or in combinations. Figure 3 shows the overall results of these experiments. The general trend was that butyrate further enhanced the cytokine induced increase of HLA class I, HLA class II, secretory component, and ICAM-1 but with two exceptions: (a) coincubation with butyrate selectively decreased the enhancement of HLA class I expression caused by TNF even in the presence of other cytokines; and (b) the enhancement of secretory component expression caused by IL over four days in combination with IFN, TNF, IL 1, IFN and TNF, or IFN and IL 1 (100 IU/ml of each cytokine) on the last day (Fig 4) (Fig 4) . The could result in less poly-Ig transport and thereby suboptimal protection of the mucosal surfaces. Furthermore, it might be expected that changed butyrate concentrations would significantly influence the cytokine mediated responses taking place in inflammatory gut lesions. In conclusion, our findings should encourage further studies of the interplay between the luminal bacterial flora, its fermentation products, and the mucosal immune system.
